✦ LIBER ✦

Raloxifene and cardiovascular events in osteoporotic postmenopausal women. Four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial

✍ Scribed by E. Barrett-Connor; D. Grady; A. Sashegyi

Book ID: 114347072
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 35 KB
Volume: 11
Category: Article
ISSN: 1062-1458
DOI: 10.1016/s1062-1458(02)00692-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk-Benefit Profile for Raloxifene: 4-Y

Risk-Benefit Profile for Raloxifene: 4-Year Data From the Multiple Outcomes of Raloxifene Evaluation (MORE) Randomized Trial

✍ Elizabeth Barrett-Connor; Jane A Cauley; Pandurang M Kulkarni; Andreas Sashegyi; 📂 Article 📅 2004 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 90 KB

Use of health-related quality of life me

Use of health-related quality of life measures to predict health utility in postmenopausal osteoporotic women: results from the Multiple Outcomes of Raloxifene Evaluation study

✍ Burge, Russel; Shen, Wei; Naegeli, April N; Alam, Jahangir; Silverman, Stuart; G 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 204 KB

Post hoc analysis of data from the Multi

Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes

✍ Elizabeth Barrett-Connor; Kristine E. Ensrud; Kristine Harper; Timothy M. Mason; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 876 KB

A Global Study of Vitamin D Status and P

A Global Study of Vitamin D Status and Parathyroid Function in Postmenopausal Women with Osteoporosis: Baseline Data from the Multiple Outcomes of Raloxifene Evaluation Clinical Trial

✍ Lips, Paul; Duong, Tu; Oleksik, Anna; Black, Dennis; Cummings, Steven; Cox, Davi 📂 Article 📅 2001 🏛 Endocrine Society 🌐 English ⚖ 220 KB

The relationship of health-related quali

The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: Results from the Multiple Outcomes of Raloxifene Evaluation Study

✍ Stuart L. Silverman; Michael E. Minshall; Wei Shen; Kristine D. Harper; Sunny Xi 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 2 views

Teriparatide and raloxifene reduce the r

Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials. Bouxsein ML, Chen P, Glass EV, Kallmes DF, Delmas PD, Mitlak BH. J Bone Joint Surg Am. 2009;91(6):1329–38

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 59 KB